-
Listing
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextLeggi tuttoWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Informazioni sul trading
Where European Government Bonds meet the futureFixed Income derivativesLeggi tuttoTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLeggi tuttoEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLeggi tuttoEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Leggi tuttoThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperNext generation of indicesLeggi tuttoThis white paper marks the second edition of Euronext’s Index Outlook series, a recurring publication designed to give investors deeper insight into our index innovation agenda and the structural forces shaping global markets.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Leggi tuttoShaping capital markets for future generations
Bell Ceremony to welcome the 2014 European Biotech Week in Brussels
08/10/2014
On 8 October 2014, Nathalie Moll, Secretary General of EuropaBio rang the Opening Bell together with Karin Baudin, VP Technology Transfer InsermTransfert of ENTENTE Project at Euronext Brussels. At this event, the partners of the ENTENTE-project together with the European Commission and EuropaBio announced on the podium the 5th Most Innovative European Biotech SME Award and the ENTENTE Life Sciences Investment Forum, which are taking place during the 2014 European Biotech Week in Brussels.
Ruxandra Draghia-Akli, Director, Directorate Health at DG Research and Innovation of the European Commission has held a short speech as well during the Bell Ceremony.
To know more : www.biotechweek.org